Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV731
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,586
Award facts
- Contract value 100% obligated
- $22,586.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $22,586.32 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pens on January 22, 2026, with completion targeted for January 23, 2026. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a single task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. That primary IDC, valued at up to $999.99 million through December 2031, serves as the comprehensive vehicle for delivering pharmaceuticals and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location where this order will be fulfilled—is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery of Zepbound, a diabetes medication, aligns with the company's established portfolio of supplying endocrinology treatments to military and veteran healthcare systems. This order exemplifies the routine medical commodity deliveries executed under the broader DLA Medical Supply Chain vehicle, demonstrating AmerisourceBergen's capability to meet federal requirements through competitive procurement on an open basis.
Quick answers
Who was awarded contract SPE2DR26FV731?
SPE2DR26FV731 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FV731 worth?
The government has obligated $22,586 on SPE2DR26FV731.
Is contract SPE2DR26FV731 an order under another contract?
Yes. SPE2DR26FV731 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV731 competed?
The extent of competition for SPE2DR26FV731 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award